Interview- Meet Our New FAS, Lisa Creary

29/10/2020

We are happy to announce that Lisa Creary joined Omixon as a Field Application Scientist effective October, 2020. In the following mini-interview Lisa talks about her passion, experiences and thoughts on HLA activities. Welcome Lisa! How did you become a scientist? My first experience of science dates back many moons...

Shipping and Working Days During Holiday Breaks 2020

05/10/2020

We are slowly approaching the end of 2020, so Omixon would like to inform all our customers of important operational dates during the end of year holiday period. General Holiday Closure Our offices will be closed from 24th December until 27th December 2020 and on 1st January 2021. We...

Omixon Launches AzureSeq-200 CE IVD Kit For One-step RT-qPCR Detection of SARS-CoV-2 and Announces Exclusive Agreement with SeqOnce Biosciences

05/10/2020

As much as Omixon wants to stay focused on the needs of histocompatibility labs, the current coronavirus pandemic calls for innovation in the field of viral detection based on molecular diagnostics. Omixon has used its product development capabilities and collaboration network to develop a truly innovative product addressing an...

Omixon Launches OmniType, Multiplex For NGS-based HLA Genotyping

30/09/2020

Omixon proudly announces the launch of OmniType, a 11-locus multiplex human leukocyte antigen (HLA) genotyping assay and software product for use on the Illumina® sequencing platforms (such as MiSeq, MiniSeq and iSeq). OmniType offers a revolutionary single working-day workflow that allows processing of samples from gDNA to a ready-to-sequence...

Webinar – HLA Genotype Shapes JAK2 V617F Driven Oncogenesis

21/09/2020

Join us for a webinar with Prof. Milena Ivanova MD (Molecular Biologist, Lab Co-Director at the Dept. of Clinical Immunology, University Hospital Aleksandrovska, Sofia, Bulgaria) and Libor Kolesár (Senior Field Applications Scientist & Assay Product Manager, Omixon). HLA class I and class II alleles have been shown to...